Four Main Virotypes among Extended-Spectrum-β-Lactamase-Producing Isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, Epidemiological, and Clinical Characteristics

被引:71
|
作者
Blanco, Jorge [1 ]
Mora, Azucena [1 ]
Mamani, Rosalia [1 ]
Lopez, Cecilia [1 ]
Blanco, Miguel [1 ]
Dahbi, Ghizlane [1 ]
Herrera, Alexandra [1 ]
Marzoa, Juan [1 ]
Fernandez, Val [2 ,3 ]
de la Cruz, Fernando [2 ,3 ]
Martinez-Martinez, Luis [2 ,4 ]
Pilar Alonso, Maria [5 ]
Nicolas-Chanoine, Marie-Helene [6 ,7 ]
Johnson, James R. [8 ,9 ]
Johnston, Brian [8 ,9 ]
Lopez-Cerero, Lorena [10 ]
Pascual, Alvaro [10 ,11 ]
Rodriguez-Bano, Jesus [10 ,12 ]
机构
[1] Univ Santiago de Compostela, Fac Vet, Dept Microbiol & Parasitol, Lab Referencia Coli E, Lugo, Spain
[2] Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain
[3] Inst Biomed & Biotecnol Cantabria, Santander, Spain
[4] Hosp Univ Marques de Valdecilla, IFIMAV, Microbiol Serv, Santander, Spain
[5] Hosp Univ Lucus Augusti, Unidade Microbiol Clin, Lugo, Spain
[6] Hop AP HP Beaujon, Microbiol Serv, Clichy, France
[7] Univ Paris 07, Fac Med D Diderot, Paris, France
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain
[11] Fac Med, Dept Microbiol, Seville, Spain
[12] Univ Seville, Dept Med, Seville, Spain
关键词
SEQUENCE TYPE ST131; VIRULENCE GENE CONTENT; E; COLI; CLONAL GROUP; CTX-M; KLEBSIELLA-PNEUMONIAE; STRAINS; SPREAD; EMERGENCE; PREVALENCE;
D O I
10.1128/JCM.01555-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 1,021 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBLEC) isolates obtained in 2006 during a Spanish national survey conducted in 44 hospitals were analyzed for the presence of the O25b:H4-B2-ST131 (sequence type 131) clonal group. Overall, 195 (19%) O25b-ST131 isolates were detected, with prevalence rates ranging from 0% to 52% per hospital. Molecular characterization of 130 representative O25b-ST131 isolates showed that 96 (74%) were positive for CTX-M-15, 15 (12%) for CTX-M-14, 9 (7%) for SHV-12, 6 (5%) for CTX-M-9, 5 (4%) for CTX-M-32, and 1 (0.7%) each for CTX-M-3 and the new ESBL enzyme CTX-M-103. The 130 O25b-ST131 isolates exhibited relatively high virulence scores (mean, 14.4 virulence genes). Although the virulence profiles of the O25b-ST131 isolates were fairly homogeneous, they could be classified into four main virotypes based on the presence or absence of four distinctive virulence genes: virotypes A (22%) (afa FM955459 positive, iroN negative, ibeA negative, sat positive or negative), B (31%) (afa FM955459 negative, iroN positive, ibeA negative, sat positive or negative), C (32%) (afa FM955459 negative, iroN negative, ibeA negative, sat positive), and D (13%) (afa FM955459 negative, iroN positive or negative, ibeA positive, sat positive or negative). The four virotypes were also identified in other countries, with virotype C being overrepresented internationally. Correspondingly, an analysis of XbaI macrorestriction profiles revealed four major clusters, which were largely virotype specific. Certain epidemiological and clinical features corresponded with the virotype. Statistically significant virotype-specific associations included, for virotype B, older age and a lower frequency of infection (versus colonization), for virotype C, a higher frequency of infection, and for virotype D, younger age and community-acquired infections. In isolates of the O25b:H4-B2-ST131 clonal group, these findings uniquely define four main virotypes, which are internationally distributed, correspond with pulsed-field gel electrophoresis (PFGE) profiles, and exhibit distinctive clinical-epidemiological associations.
引用
收藏
页码:3358 / 3367
页数:10
相关论文
共 50 条
  • [31] Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance
    Lopez-Cerero, Lorena
    del Mar Bellido, Maria
    Serrano, Lara
    Liro, Julia
    Miguel Cisneros, Jose
    Rodriguez-Bano, Jesus
    Pascual, Alvaro
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (06): : 385 - 388
  • [32] Molecular Characteristics of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
    Pitout, Johann D. D.
    Gregson, Daniel B.
    Campbell, Lorraine
    Laupland, Kevin B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 2846 - 2851
  • [33] Dissemination of the multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli O25b-ST131 clone and the role of house crow (Corvus splendens) foraging on hospital waste in Bangladesh
    Hasan, B.
    Olsen, B.
    Alam, A.
    Akter, L.
    Melhus, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (11) : 1000.e1 - 1000.e4
  • [34] Whole Genome Sequencing and Characteristics of mcr-1-Harboring Plasmids of Porcine Escherichia coli Isolates Belonging to the High-Risk Clone O25b:H4-ST131 Clade B
    Flament-Simon, Saskia-Camille
    de Toro, Maria
    Mora, Azucena
    Garcia, Vanesa
    Garcia-Menino, Isidro
    Diaz-Jimenez, Dafne
    Herrera, Alexandra
    Blanco, Jorge
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [35] Antibacterial Efficacy of N-(4-methylpyridin-2-yl) Thiophene-2-Carboxamide Analogues against Extended-Spectrum-β-Lactamase Producing Clinical Strain of Escherichia coli ST 131
    Ahmad, Gulraiz
    Khalid, Aqsa
    Qamar, Muhammad Usman
    Rasool, Nasir
    Saadullah, Malik
    Bilal, Muhammad
    Bajaber, Majed A.
    Obaidullah, Ahmad J.
    Alotaibi, Hadil Faris
    Alotaibi, Jawaher M.
    MOLECULES, 2023, 28 (07):
  • [36] Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes
    Brisse, Sylvain
    Diancourt, Laure
    Laouenan, Cedric
    Vigan, Marie
    Caro, Valerie
    Arlet, Guillaume
    Drieux, Laurence
    Leflon-Guibout, Veronique
    Mentre, France
    Jarlier, Vincent
    Nicolas-Chanoine, Marie-Helene
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (09) : 2974 - 2981
  • [37] Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain
    Mora, Azucena
    Blanco, Miguel
    Lopez, Cecilia
    Mamani, Rosalia
    Blanco, Jesus E.
    Pilar Alonso, Maria
    Garcia-Garrote, Fernando
    Dahbi, Ghizlane
    Herrera, Alexandra
    Fernandez, Ana
    Fernandez, Begona
    Agulla, Andres
    Bou, German
    Blanco, Jorge
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (01) : 16 - 21
  • [38] Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes
    Morales-Barroso, Isabel
    Lopez-Cerero, Lorena
    Molina, Jose
    Bellido, Mar
    Dolores Navarro, Maria
    Serrano, Lara
    Gonzalez-Galan, Veronica
    Praena, Julia
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (04) : 498 - 502
  • [39] The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities
    Vimont, Sophie
    Boyd, Anders
    Bleibtreu, Alexandre
    Bens, Marcelle
    Goujon, Jean-Michel
    Garry, Louis
    Clermont, Olivier
    Denamur, Erick
    Arlet, Guillaume
    Vandewalle, Alain
    PLOS ONE, 2012, 7 (09):
  • [40] Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15
    Pouillot, Flavie
    Chomton, Maryline
    Blois, Helene
    Courroux, Celine
    Noelig, Julien
    Bidet, Philippe
    Bingen, Edouard
    Bonacorsi, Stephane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3568 - 3575